Fred Hutchinson Cancer Research Center

Y-shaped antibodies specific for individual CMV strains (depicted by same color) can prevent the virus from reactivating after transplantation. Other CMV strains (depicted in black) can escape.

Rethinking an old viral foe

Cytomegalovirus, or CMV, has plagued bone marrow transplant patients for decades. A new study in Science may rewrite the story of why the virus wreaks such havoc — and hint at how to stop it.

A graphic that depicts the decline in U.S. cancer death rates over the past 25 years

US cancer death rate has declined for at least 25 years

Fred Hutch experts weigh in on milestone report from American Cancer Society

Illustration of potential clinical trial participants

How to boost participation in cancer clinical trials

New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients

Photo of Michael Zager demonstrating Oncoscape, a web-based collaboration platform for sharing translational data.

Why we are counting on data science and tech to defeat cancer

Fred Hutch President and Director Dr. Gary Gilliland reflects on recent progress in cancer research and what he sees ahead in 2019.

CURES START HERE

Disease Research

Our world-class scientists, including three Nobel Laureates, have revolutionized prevention, detection and treatment for several cancers and other diseases.

Clinical Trials and Studies

Find a Trial or Study

We have more than 300 treatment trials or healthy volunteer studies currently open. Help advance groundbreaking treatments by enrolling today.

Integrated Research Center

Immunotherapy

Our integrated approach is speeding the development of new and better immunotherapies for patients with solid tumor cancers, blood cancers and other non-cancerous disorders.

Upcoming Events

Slayride Banked Slalom

Join us at Stevens Pass for Slayride Banked Slalom. Open to both skiers and boarders of all abilities. There will be fundraising prizes, a beer garden and much more.

See all events

GOOD NEWS

Achievements

Dr. Kristin Anderson, a postdoctoral research fellow in Dr. Philip Greenberg’s lab, has received a one-year, $75,000 award from the Ovarian Cancer Research Alliance.